NCT06249399 is a NA clinical trial of Aerobic Exercise in Lower Urinary Tract Symptoms, sponsored by Gaziantep Islam Science and Technology University.

Who is sponsoring NCT06249399?

NCT06249399 is sponsored by Gaziantep Islam Science and Technology University.

What drugs are being tested in NCT06249399?

Interventions in NCT06249399: Aerobic Exercise, Behavioral Treatment Program.

What condition does NCT06249399 study?

NCT06249399 studies Lower Urinary Tract Symptoms, Diabetes Mellitus, Type 2.

Is NCT06249399 still recruiting?

NCT06249399 is currently completed. Last updated 5 March 2024.

Last reviewed 2024-03-05 · How we verify

NCT06249399

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

The Effect of Aerobic Exercise on Lower Urinary System Symptoms in Women With Diabetes Mellitus

Completed NA Last updated 5 March 2024

What this trial tests

NA trial testing Aerobic Exercise in Lower Urinary Tract Symptoms in 44 participants. Completed in 1 March 2024.

Timeline

3 May 2023

Primary endpoint
1 March 2024

1 March 2024

Quick facts

Lead sponsor	Gaziantep Islam Science and Technology University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	44
Start date	3 May 2023
Primary completion	1 March 2024
Estimated completion	1 March 2024
Sites	1 location across Turkey (Türkiye)

Drugs / interventions tested

Aerobic Exercise — full drug profile →
Behavioral Treatment Program

Conditions studied

Lower Urinary Tract Symptoms — all drugs for Lower Urinary Tract Symptoms →
Diabetes Mellitus, Type 2 — all drugs for Diabetes Mellitus, Type 2 →

Sponsor

Gaziantep Islam Science and Technology University

Who can join

Adults 35 to 55, female only, with Lower Urinary Tract Symptoms or Diabetes Mellitus, Type 2. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The goal of this clinical trial is to investigate the effect of aerobic exercise (AE) on bladder functions and urinary system symptoms in women diagnosed with Diabetes Mellitus (DM) and suffered from Lower Urinary Tract Symptoms (LUTS). In the study, 44 individuals (35-55 age) were divided into two groups: Aerobic Exercise (AE) (n=22) and Control Group (n=22) by simple random method. The main questions it aims to answer are: * Is aerobic exercise effective on bladder functions in women diagnosed with Diabetes Mellitus and suffered from Lower Urinary Tract Symptoms? * Is aerobic exercise effective on urinary tract symptoms in women diagnosed with Diabetes Mellitus and suffered from Lower Urinary Tract Symptoms? * Is aerobic exercise effective on quality of life in women diagnosed with Diabetes Mellitus and suffered from Lower Urinary Tract Symptoms? Intervention/treatment * Control group individuals will be given a behavioral treatment program. * Submaximal aerobic exercise training will be given to the AE group in addition to the behavioral treatment program.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Aerobic Exercise

Trials testing the same drug.

NCT07517224 — Assessing the Effect of an Aerobic Exercise Program on Vascular Function in Women With Non-Metastatic Breast Cancer · NA · not yet recruiting
NCT07444333 — Cardiac Output and Fatigue in Friedreich's Ataxia · NA · not yet recruiting
NCT07182006 — Exercise as Medicine for Pediatric Chronic Pain · NA · not yet recruiting
NCT07404319 — Effectiveness of Exercise Alone and tDCS+Exercise on Cognitive Function Improvement in Patients With Treatment Resistant · NA · not yet recruiting
NCT07302204 — Efficacy of Aerobic Exercise Versus Therapeutic Exercises on Exercise-induced Hypoalgesia in Knee Osteoarthritis · NA · recruiting

Other recruiting trials for Lower Urinary Tract Symptoms

Currently open trials in the same condition.

NCT06481436 — Use of Artificial Intelligence by Urogynecologic Patients · NA · active not recruiting
NCT06351683 — Testing MitoQ on Lower Urinary Tract Symptoms in Older Women With Metabolic Syndrome · Phase 2 · recruiting
NCT06225479 — PRescription Exercise for Older Men With Urinary Disease · NA · recruiting
NCT06179654 — Preoperative Pelvic Floor Physical Therapy to Minimize Stress Urinary Incontinence After Holmium Laser Enucleation of th · NA · recruiting
NCT06070675 — Comparison of a Paper and Automated Bladder Diary in Pediatric Patients · NA · recruiting

Other Gaziantep Islam Science and Technology University trials

Trials by the same sponsor.

NCT07155538 — Bed Bridge Test in Acute Stroke Patients · not yet recruiting
NCT07155161 — Backward Walking and Related Factors in Individuals With Stroke · not yet recruiting
NCT07150078 — Dual Task and Attention Deficit and Hyperactivity Disorder · completed
NCT07478562 — Thoracolumbar Fascia · NA · completed
NCT06785155 — AI Chatbot-Based Learning on Dry Eye and Eye Strain Knowledge · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06249399 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Gaziantep Islam Science and Technology University
Last refreshed: 5 March 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06249399.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing